Pfizer applies for emergency coronavirus vaccine approval in U.

It comes days after the drugmaker announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

7 191

Trump’s coronavirus vaccine team won’t brief Biden’s transition team, U.

White House spokesman Brian Morgenstern did not address whether Biden's team would be briefed, saying vaccine distribution plans from the U.S. Centers for Disease Control and Prevention and state governors were publicly available.

6 805

Pfizer says final results show coronavirus vaccine is 95% effective, no safety concerns.

A final analysis of the Phase 3 trial of Pfizer's coronavirus vaccine shows it was 95 per cent effective in preventing infections.

4 513

Pfizer launches pilot delivery program for potential coronavirus vaccine in 4 states.

Pfizer's vaccine candidate was shown to be more than 90% effective in preventing COVID-19 based on initial data, but the company faces distribution and storage challenges.

4 43

Trump vows against U.S. coronavirus lockdown in 1st speech since election defeat

Trump's defiant remarks comes amid a record breaking surge in new COVID-19 cases in the United States.

4 1991

EU to secure up to 300 million doses of Pfizer-BioNTech coronavirus vaccine: commission.

Pfizer said Monday that early results from the vaccine suggests the shots may be a surprisingly robust 90 per cent effective at preventing COVID-19.

4 22

BioNTech, Pfizer to price coronavirus vaccine below ‘typical market rates’.

BioNTech, first in the race to produce evidence of a working COVID-19 vaccine, is planning to price the two-shot regimen below "typical market rates."

5 229

Pfizer’s coronavirus vaccine: Here’s what experts are saying about the new data.

Although Pfizer's coronavirus vaccine data looks promising, experts say we should remain 'cautious' as the full data has still not been released.

7 1165

Pfizer’s coronavirus vaccine may be 90% effective, early data suggests.

Pfizer cautioned the initial protection rate might change by the time the study ends. Even revealing such early data is highly unusual.

7 3157

Coronavirus vaccine: Pfizer may ask for emergency approval in late November.

Pfizer said on Friday it may file for authorization of the COVID-19 vaccine it is developing with German partner BioNTech in late November.

1 609

Coronavirus vaccine trials: Pfizer plans to include participants as young as 12.

The trial, which is being conducted in four countries including the United States, has enrolled more than 37,000 participants.

1 1484